-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Landscape of SCD Treatment Options and New Therapies

Program: Special-Interest Sessions
Session: Clinical Care and Research Implications Following Voxelotor Withdrawal
Monday, December 9, 2024, 10:30 AM-12:00 PM

Alexis Thompson, MD, MPH

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Disclosures: No relevant conflicts of interest to declare.

See more of: Clinical Care and Research Implications Following Voxelotor Withdrawal
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation